Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Arkansas health official outlines vaccine timeline, warns of surge and limited initial supply
Summary
Dr. Romero of the Arkansas Department of Health told the Public Health, Welfare and Labor Committee that a Pfizer vaccine EUA was expected for mid-December, initial state allotments would be small (planning ~25,000 doses), two-dose regimens and cold-storage limits complicate rollout, and ongoing safety monitoring will continue post-authorization.
Dr. Romero of the Arkansas Department of Health briefed the Senate Public Health, Welfare and Labor Committee on the expected federal approvals and state planning for COVID-19 vaccines, stressing safety monitoring and distribution challenges.
Dr. Romero said Pfizer’s vaccine was scheduled for an FDA Emergency Use Authorization visit and that the Advisory Committee on Immunization Practices (ACIP) would meet to issue interim recommendations. He described the vaccine as an RNA product with preliminary trial efficacy above 90 percent and a reactogenicity profile that can include fever and injection-site pain. “We are not going to turn this vaccine loose on the public without further scrutiny,” he told the committee, noting that both the FDA and ACIP review safety and efficacy data and that post-authorization (post‑marketing) surveillance will look for rare events.
Why it matters: Arkansas will receive vaccine allocations on a per-capita basis and the initial allotment will not be sufficient to vaccinate everyone who wants it. State planning…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
